NASDAQ Equity Snapshot
EDIT Weekly Equity Report
Editas Medicine Inc
What the company does
Editas Medicine, Inc., a clinical-stage genome editing company, is focused on developing transformative genomic drugs to treat a variety of serious diseases. The company is headquartered in Cambridge, Massachusetts.
What the weekly tape is saying
EDIT closed the latest completed week at 2.50 USD. The 4-week return is -4.6% and the 12-week return is 6.8%. Trend Signal is active, Market Dynamics is 0.52. Setup signature: Risk-first tape with a 32/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 2.44 USD
- Vs Trend Line
- 2.4%
- Fair Value
- 4.38 USD
- Vs Fair Value
- -43.0%
- 52W High
- 4.54 USD
- 52W Low
- 1.66 USD
- Drawdown
- -44.9%
- Range Position
- 29.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 5 weeks
- 52W Active Weeks
- 28
- 52W Active Breadth
- 53.8%
- Sector Scope
- US Healthcare
- Sector Rank
- 911 of 1038
- Sector Percentile
- 12.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.52
- 4W MD Change
- -17.6%
- Relative Strength
- -19.89
- 4W RS Change
- -44.4%
- Expectation
- Negative
- Probability
- 44.40%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 9.0M
- 13W Average
- 9.8M
- 52W Average
- 10.5M
- Vs 13W
- 0.9x
- Vs 52W
- 0.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 14.3%
- 52W Volatility
- 12.7%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 11.7% / -8.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 527.9M
Opportunity signals
- Trend Signal is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.50 USD | -7.7% | 2.44 USD | 4.38 USD | 0.52 | -19.89 | 9.0M | On |
| 5 Jun 2026 | 2.71 USD | -21.7% | 2.44 USD | 4.42 USD | 0.62 | -11.27 | 15.1M | On |
| 29 May 2026 | 3.46 USD | 25.4% | 2.44 USD | 4.47 USD | 0.72 | 8.30 | 35.5M | On |
| 22 May 2026 | 2.76 USD | 5.3% | 2.42 USD | 4.51 USD | 0.52 | -10.57 | 5.6M | On |
| 15 May 2026 | 2.62 USD | -15.8% | 2.46 USD | 4.55 USD | 0.63 | -13.77 | 5.5M | On |
| 8 May 2026 | 3.11 USD | 7.2% | 2.49 USD | 4.59 USD | 0.89 | 2.38 | 6.1M | Off |
| 1 May 2026 | 2.90 USD | -0.3% | 2.51 USD | 4.63 USD | 0.94 | 1.35 | 6.3M | Off |
| 24 Apr 2026 | 2.91 USD | -16.6% | 2.55 USD | 4.68 USD | 0.96 | 3.71 | 7.2M | Off |
| 17 Apr 2026 | 3.49 USD | 18.7% | 2.56 USD | 4.71 USD | 0.83 | 27.91 | 9.3M | Off |
| 10 Apr 2026 | 2.94 USD | 10.1% | 2.54 USD | 4.74 USD | 0.56 | 15.73 | 7.5M | Off |
| 2 Apr 2026 | 2.67 USD | 19.7% | 2.53 USD | 4.77 USD | 0.53 | 10.78 | 6.8M | Off |
| 27 Mar 2026 | 2.23 USD | -4.7% | 2.53 USD | 4.80 USD | 0.30 | -2.83 | 6.8M | Off |
| 20 Mar 2026 | 2.34 USD | -4.1% | 2.54 USD | 4.83 USD | 0.25 | -0.73 | 6.3M | Off |
| 13 Mar 2026 | 2.44 USD | 22.0% | 2.56 USD | 4.86 USD | -0.19 | 2.10 | 14.1M | Off |